Merit Medical Systems (MMSI) Tops Q2 EPS by 3c; Raises Outlook
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/22/2026
- Wall St futures pause after AI rally, focus on Mideast tensions
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Oil price dips to $100 on hopes of US-Iran diplomacy, partial recovery in Saudi exports
- Paramount, Warner Bros jump on report of settlement progress in merger fight
- Investors may be underpricing how far rate hikes could go, Deutsche says
- Pennsylvania measles cases near 800 as outbreak grows
- A timeline of Trump administration moves to weaken endangered species protections
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Nasdaq notches record-high close, AI optimism reignites and Treasury yields retreat
- SpaceX and Tesla’s AI linkup is getting deeper. Here’s what Morgan Stanley sees
Merit Medical Systems (MMSI) Announces Proposed 3.5M Share Common Offering
July 24, 2018 4:14 PM EDTMerit Medical Systems, Inc. (NASDAQ: MMSI) today announced that it has commenced an underwritten public offering of shares of its common stock. Merit expects to offer 3,500,000 shares of common stock and also plans to grant the underwriters participating in the offering a 30-day... More
Merit Medical Systems, Inc. (MMSI) PT Raised to $61 at Barrington Research
July 24, 2018 8:30 AM EDTBarrington Research raised its price target on Merit Medical Systems, Inc. (NASDAQ: MMSI) to $61.00 (from $50.00) while maintaining a Outperform rating.
... MoreMerit Medical Systems, Inc. (MMSI) PT Raised to $70 at Canaccord Genuity
July 24, 2018 7:08 AM EDTCanaccord Genuity raised its price target on Merit Medical Systems, Inc. (NASDAQ: MMSI) to $70.00 (from $60.00) while maintaining a Buy rating.
... MoreMerit Medical Systems, Inc. (MMSI) PT Raised to $67 at Needham & Company
July 24, 2018 6:31 AM EDTNeedham & Company raised its price target on Merit Medical Systems, Inc. (NASDAQ: MMSI) to $67.00 (from $54.00) while maintaining a Buy rating.
Analsyt Mike Matson commented, "MMSI's 2Q18 revenue and EPS beat consensus. Management raised its 2018 revenue and EPS guidance but lowered its 2018 gross margin... More
